Independent news has never been so important.

Did you know that you can get Democracy Now! delivered to your inbox every day? Sign up for our Daily News Digest today! Don't worry, we'll never share or sell your information.

Oxfam Files Complaint Against Moderna; EU Approves Novavax COVID Vaccine

HeadlineDec 22, 2021

Oxfam America, a Moderna shareholder, has filed a complaint against the drug company with the Securities and Exchange Commission. A lawyer for Oxfam said, “Instead of … using its life-saving technology to help curb the pandemic, Moderna is … obfuscating its patent dispute with the US government, ignoring the death and suffering of millions worldwide, and declining to share their technology to help alleviate the stranglehold that COVID-19 has placed on the global economy.”

In other vaccine news, European Union regulators have approved Novavax’s vaccine for people 18 and older. Tests have shown the U.S.-developed shot to be roughly 90% effective, though there is limited data on its efficacy against variants of concern, including Omicron. Novavax will start delivering vaccines to the EU in January.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation